Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin L Madison

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|March 17, 2011
Proteases as therapeuticsCharles S Craik, Michael J Page, Edwin L Madison
The FEBS Journal|March 29, 2007
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase familyOtto J P Kyrieleis, Robert Huber, Edgar Ong, et al.
Biochemistry|May 7, 2003
Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysisRobert C Bergstrom, Gary S Coombs, Sheng Ye, et al.
Cancer Metastasis Reviews|June 6, 2003
Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancerSarah Netzel-Arnett, John D Hooper, Roman Szabo, et al.
The Prostate|September 16, 2004
CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenograftsAnna V Galkin, Lynne Mullen, William D Fox, et al.
The Journal of Biological Chemistry|November 7, 2001
Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinaseRainer Friedrich, Pablo Fuentes-Prior, Edgar Ong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|March 17, 2011
Proteases as therapeuticsCharles S Craik, Michael J Page, Edwin L Madison
The FEBS Journal|March 29, 2007
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase familyOtto J P Kyrieleis, Robert Huber, Edgar Ong, et al.
Biochemistry|May 7, 2003
Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysisRobert C Bergstrom, Gary S Coombs, Sheng Ye, et al.
Cancer Metastasis Reviews|June 6, 2003
Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancerSarah Netzel-Arnett, John D Hooper, Roman Szabo, et al.
The Prostate|September 16, 2004
CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenograftsAnna V Galkin, Lynne Mullen, William D Fox, et al.
The Journal of Biological Chemistry|November 7, 2001
Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinaseRainer Friedrich, Pablo Fuentes-Prior, Edgar Ong, et al.
Pageof 1